Keywords
pharmaceutical compounding
quality control
How to Cite
Abstract
The authors report a case on an inaccurate pharmacy compounding of digitoxin compounded preparation, which revealed an amount of 565% of active digitoxin in reference to that concentration stated in the label. The preparation analysis request was sent with a clinical record and sanitary authority notification on severe digitalic intoxication symptoms presented by the patient after taking that medication. The reported episode points up the lack of quality control at compounding pharmacies during dispensing drugs and compounds, with narrow therapeutic indices as digitalis drug preparations.References
1. Korolkovas A, Burckhalter, JH Química farmacêutica Rio de Janeiro: Guanabara Koogan; 1982, 783p.
2. Goodman & Gilman ́s the pharmacological basis of theurapeutics. 10aed., editores Hardman, JG e Limbird, LE. New York: McGraw-Hill, 2001, 2148p.
3. Sweetman SC The Martindale the complete drug reference, 34a ed, London: Pharmaceutical Press; 2005, 2756p.
4. European Pharmacopoeia 3a. ed Strasbourg: Council of Europe, 1997,1440p.
5. The United States Pharmacopeia 28.ed. Rockville: United States Pharmacopeial Conventions; 2005, 3187p.
6. Brasil, Leis e Decretos - RDC no. 33 de 19 de abril de 2000 da AgênciaNacional de Vigilância Sanitária do Ministério da Saúde. Aprova regulamento técnico que institui as Boas Práticas de Manipulação em Farmácias . DOU de 24 de abril de 2000, no. 78-E, seção 1, p. 27.
7. Boletim Informativo ANVISA - Manipulação segura. Brasília: Ministério da Saúde; vol 56 (junho), 2005, p.1 – 11.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2005 Instituto Adolfo Lutz Journal